DWTX

Dogwood Therapeutics, Inc. - Common Stock (DWTX)

About Dogwood Therapeutics, Inc. - Common Stock (DWTX)

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Details

Daily high

$6.05

Daily low

$5.41

Price at open

$5.67

52 Week High

$29.28

52 Week Low

$1.62

Market cap

10.6M

Dividend yield

0.00%

Volume

352,479

Avg. volume

2.6M

P/E ratio

-.50

Dogwood Therapeutics, Inc. - Common Stock News